Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)
BelgiumLong-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2
BelgiumLong-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001
BelgiumStudy on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1
BelgiumStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
BelgiumEfficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy
BelgiumStudy of Microdystrophin (GNT0004) Gene Therapy for Duchenne Muscular Dystrophy in Boys Who Can Walk
BelgiumPhase 3 Randomized Double‑Blind Placebo‑Controlled Study of Intravenous sgt-003 in Ambulatory Male Patients with Duchenne Muscular Dystrophy
BelgiumStudy on the Effects of Rapcabtagene Autoleucel and Drug Combination for Patients with Severe Refractory Inflammatory Muscle Diseases
BelgiumStudy on the Safety and Effectiveness of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy
BelgiumStudy on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis
BelgiumA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
Belgiumpowered by
